Medical Economics Pulse

25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

3 min · 15. aug. 2025
episode 25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment cover

Description

This week’s Weekly Dose covers new Endocrine Society guidelines on preexisting diabetes in pregnancy and primary aldosteronism screening, a digital asthma management tool that improved symptoms but revealed disparities, public perceptions of physicians using AI, evidence linking GLP-1 receptor agonists to reduced dementia risk, and the FDA’s first approved treatment for chronic hand eczema.

Comments

0

Be the first to comment

Sign up now and become a member of the Medical Economics Pulse community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

28 episodes

episode 30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes artwork

30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes

In this episode of the Weekly Dose podcast by Patient Care Online, we review recent studies on key clinical topics: the heightened risk of depression after chronic illness diagnosis, the safety of vaginal estradiol for women with prior stroke, the approval of generic liraglutide for obesity, the potential cancer risk reduction with GLP-1 therapies, and cardiovascular benefits of semaglutide in patients with obesity. The episode highlights important findings and their implications for clinical practice, offering health care professionals timely updates across mental health, women’s health, obesity management, cancer prevention, and cardiovascular care.

24. sept. 20254 min